Clinical trials
Breast Neoplasms trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
245 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 6 |
| 2005 | 7 |
| 2006 | 16 |
| 2007 | 9 |
| 2008 | 12 |
| 2009 | 10 |
| 2010 | 8 |
| 2011 | 15 |
| 2012 | 16 |
| 2013 | 9 |
| 2014 | 12 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 12 |
| 2019 | 10 |
| 2020 | 15 |
| 2021 | 17 |
| 2022 | 13 |
| 2023 | 10 |
| 2024 | 2 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 150 |
| Active, not recruiting | 33 |
| Terminated | 27 |
| Unknown status | 19 |
| Recruiting | 11 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 34 |
| Novartis Pharmaceuticals | 26 |
| AstraZeneca | 23 |
| Tomsk National Research Medical Center of the Russian Academy of Sciences | 14 |
| Pfizer | 13 |
| Eli Lilly and Company | 11 |
| GlaxoSmithKline | 8 |
| Biocad | 6 |
| N.N. Petrov National Medical Research Center of Oncology | 6 |
| Sanofi | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 245 |
| Neoplasm Metastasis | 31 |
| Neoplasms | 22 |
| Prostatic Neoplasms | 8 |
| Triple Negative Breast Neoplasms | 8 |
| Neutropenia | 6 |
| Breast Diseases | 5 |
| Lung Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
Trials
Showing 26 to 50 of 245. Each trial links to its page on Pharma Observatory.
145 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.